Dr. Richard Graham
Advertisement
Dr. Richard Graham is chairman of the board at Tru Technologies.
Articles by Dr. Richard Graham
Dr. Richard Graham discusses the distinction between real-time data and real-time oversite and how one option may present better results than the other.
Dr. Richard Graham details how real-time data review may reduce timelines but also allow for bad data or outcomes.
Dr. Richard Graham explains how FDA’s new program allows for the usage of real-time data during clinical trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
2
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
3
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
4
New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge
5